BioSig Technologies, Inc. Stock price
Equities
BSGM
US09073N3008
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.661 USD | -9.45% | +24.72% | -86.08% |
Mar. 12 | BioSig Technologies Inc. Issues Promissory Note to an Investor for $500,000 | CI |
Mar. 07 | BioSig Technologies, Inc. announced that it has received $0.5 million in funding | CI |
Financials (USD)
Sales 2023 * | 100K | Sales 2024 * | 1.5M | Capitalization | 6.17M |
---|---|---|---|---|---|
Net income 2023 * | -27M | Net income 2024 * | -13M | EV / Sales 2023 * | 61.7 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 4.11 x |
P/E ratio 2023 * |
-0.18
x | P/E ratio 2024 * |
-0.44
x | Employees | 47 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 77.44% |
1 day | -9.45% | ||
1 week | +24.72% | ||
Current month | -3.64% | ||
1 month | -11.87% | ||
3 months | -86.06% | ||
6 months | -86.26% | ||
Current year | -86.08% |
Managers | Title | Age | Since |
---|---|---|---|
Frederick Hrkac
CEO | Chief Executive Officer | 58 | Feb. 26 |
Lora Mikolaitis
ADM | Chief Administrative Officer | 51 | 09-02-23 |
Chief Tech/Sci/R&D Officer | 74 | 09-02-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 74 | 09-02-23 | |
Frederick Hrkac
CEO | Chief Executive Officer | 58 | Feb. 26 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 0.661 | -9.45% | 272,267 |
24-03-27 | 0.73 | +55.32% | 353,438 |
24-03-26 | 0.47 | -14.36% | 100,329 |
24-03-25 | 0.5488 | +1.82% | 46,703 |
24-03-22 | 0.539 | +1.70% | 64,097 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.08% | 6.17M | |
+9.50% | 222B | |
+7.95% | 185B | |
+18.30% | 141B | |
+18.47% | 100B | |
+7.83% | 68.36B | |
+25.32% | 57.52B | |
-3.69% | 46.84B | |
+4.66% | 42.64B | |
+15.12% | 29.09B |